BACKGROUND/OBJECTIVES: Restrictive Anorexia nervosa (ANR) is an eating disorder (ED) characterized by a low bone mineral content (BMC) and by an alteration in body composition (reduction and abnormal distribution of fat mass-FM and lean mass-LM). The aim of our study was to address whether bone and body composition changes could be influenced by hormonal status and sport in female adolescents with restrictive anorexia nervosa-ANR. SUBJECTS/METHODS: Prospective study on 79 adolescents with ANR submitted to Dual Energy X-Ray Absorptiometry-DXA at baseline-T0 and after 12 months-T12. Among the 46/79-58.2% patients that completed the study, we evaluated total and regional FM and LM%, as well as lumbar bone mineral density (BMD) and Z-score, linking them to clinical variables: menarche/amenorrhea/ hormonal therapy and physical activity. RESULTS: At T0: body mass index (BMI) ¼ 16.4 ± 1.4 kg/m 2 with low levels of FM% (21.7 ± 5.7) low BMC in 12/46-26.0% (mean Z-score: À 1.21 ± 1.27, with higher values related to physical activity-P ¼ 0.001). At T12: a significant increase in BMI-P ¼ 0.001, with LM reduction and FM increase (more evident in the trunk-Po0.001); regarding bone, no significant changes were observed, though a tendency in terms of improvement associated with resumption of menses. CONCLUSIONS: After 1 year, weight recovery was not associated with a reestablishment of bone values; by contrast, it was associated with an increase and a distortion in FM distribution, more evident in trunk region (potential and adjunctive risk factor for the relapse of the psychiatric condition). The complexity of these clinical findings suggested DXA, a low-dose and low-cost technique, in long-term monitoring of ANR patients.
INTRODUCTION
Restrictive Anorexia Nervosa (ANR) is a clinical mental disorder defined as abnormal eating behaviors that can be diagnosed only by strict criteria. 1 Eating disorders (ED) are behavioral syndromes associated with considerable morbidity that present one of the highest mortality rates among mental illnesses.
Adolescent girls affected by ANR are at risk for irreversible bone loss, early onset of osteoporosis, and an increased fractures risk compared with healthy adolescents. 2, 3 Bone remodeling is a process that begins at conception and continues throughout the life. Bone remodeling balance, as determined by the interaction between bone formation and bone resorption, is crucial for the well-being of the skeletal system. 4 Adolescence and young adulthood are periods of rapid bone mass gain. Almost 25% of peak bone mass is gained during the 2 years of the peak height velocity, the so-called growth spurt. In addition, 90% of peak bone mass is achieved by the age of 18, whereas only 5-12% of bone mass is gained in the third decade of life.
There are certain factors that determine bone remodeling in adolescents and young individuals, such as genetics, gender, exercise, nutrition and endocrine factors, as well as environmental, behavioral and others. 5 The involvement of bone is a major problem in patients with ANR, both for its high incidence and for being often irreversible. 3 In addition, patients affected by ANR are reported to show an abnormal distribution of fat mass (FM) and non-bone lean mass (LM) percentage, with low level of adipose tissue, more evident in the trunk. This phenomenon is supposed to be linked both to self starvation and to hormonal status alteration. 6 Both body composition parameters (total and regional FM, LM and bone mineral content-BMC) and bone metabolism parameters (bone mineral density-BMD, and Z-score) can be assessed through a very low-dose radiological technique, such as Dualenergy X-Ray Absorptiometry (DXA). Thus, in order to address the status and the evolution of these parameters in anorexic girls under treatment, the purpose of the present study was to carry out a longitudinal prospective study on our patients, through an evaluation at baseline (start of treatment-T0) and after 12 months-T12 of:
1. Bone parameters status and changes; 2. Body mass index (BMI) variation, in association with monitoring FM and LM values and their distribution; 3. Correlation between clinical variables (sport and estrogenic condition) with both bone and body composition parameters.
MATERIALS AND METHODS

Population and study design
We carried out a 12-month prospective study on 79 female adolescents affected by ANR (mean age: 16.0 ± 3.1 years, mean period onset: 30.3 ± 24.5 months, T0-BMI: 16.1 ± 1.7 kg/m 2 ) who underwent the same multidimensional treatment protocol in our center.
During this period, patients were followed in Day-Hospital or admitted to Child NeuroPsychiatry ward, on hospitalization or post-hospitalization condition. On first admission every patient was evaluated for weight, height, BMI, pathology onset, menarche, amenorrhea, nutrition (kcal/day), physical activity (amateur-o3 times/week, competitive-43 times/week or not performing) and pharmacological therapy. They were submitted as well to DXA examination, repeated after 12 months (T12).
The study included female patients with ANR diagnosed following DSM IV criteria 7 who showed an amenorrhea condition at baseline. The exclusion criteria depended on both radiological and clinical reasons: patients who recently underwent other radiological examinations involving contrast agents and radionuclides were excluded (these may determine artifacts and abnormality/loss of values in measured DXA parameters); moreover, we did not perform DXA examination of patients affected by other types of anorexia nervosa and of patients who refused to undergo the study.
The protocol was approved by our local Ethic Committee and an informed consensus to the procedure was signed by the patients or their parents, as required.
Treatment protocol
ED treatment was structured in three different levels. Hospitalization was provided in acute conditions or to younger patients (under 18). DayHospital was adopted for patients older than 18 years old who attended the hospital every day for 2-4 months.
In all these cases, a multidisciplinary approach was given: psychodynamic treatment was integrated with family treatment, cognitivebehavioral and psycho-nutritional treatment according to organic damage, psychiatric comorbidity and family conditions.
The treatment consisted of an accurate investigation on personal and family history giving special attention to psychiatric comorbidity and weight evolution, too far and close nutritional history and physical activity history.
Objective examination came next, aimed to general health condition evaluation and constantly integrated with anthropometric data survey (weight, height and BMI). Moreover, first access examination included electrocardiogram, and biohumoral status with complete blood count, evaluation of liver, kidney and thyroid functionality, luteinizing hormone, follicle-stimulating hormone and prolactin.
One week after the first access, patients were assessed with psychometric evaluation tests, such as EDI3 (Eating Disorder Inventory-3), 8 MMPI-2 (Minnesota Multiphasic Personality Inventory 2) 9 or MMPI-A (Minnesota Multiphasic Personality Inventory-Adolescent), 10 SCID II (Structured Clinical Interview for DSM-IV-II), 11 SAFA (Self Administrated Psychiatric Scales for Children and Adolescents) 12 and CBCL (Child Behavior CheckList). 13 Minor changes were provided to the protocol, according to specific needings of the patient or the family.
During hospitalization, patients were evaluated with a psycho-educational pattern given by Child Neuropsychiatry and provided by nutritionist. All meals were assisted by psychological personal. Two consults a week were provided to the patients, one more was provided to the parents. Moreover, parents were invited to open support group for the families.
During hospitalization, upon clinical evaluation, it was possible to integrate nutrition with enteral feeding in bad damage conditions. When a serious psychiatric comorbidity occurred, worsening and perpatuating ED, pharmacological therapy was provided.
Dual-energy X-ray absorptiometry
All patients underwent a whole-body DXA scan using a new fan-beam densitometer (Lunar iDXA; enCORE 2011, software version 13.10; GE Healthcare, Madison, WI, USA), provided with a pediatric software for total body and lumbar spine AP (L1-L4) evaluation.
We evaluated total and regional FM and LM, BMD and Z-score.
To obtain body composition analysis, the patients, wearing only underwear and a cloth gown, were placed in a supine position with arms at sides slightly separated from the trunk and correctly centered on the scanning field. The scan duration was about 7 min in standard mode for total body scan. Regions of interest were areas of analysis defined by the analytical program including six different corporeal districts: total body, trunk, upper limbs, lower limbs, android region (a portion of the abdomen included between the line joining the two superior iliac crests and extended cranially up to the 20% of the distance between this line and the chin) and gynoid region (a portion of legs leaving from the femoral great throcanter, directed caudally up to a distance double of the android region). For each region, DXA scanned the weight (in g) of total mass, FM, LM, and BMC, and the percentage of FM and LM were calculated.
Measurements of lumbar DXA were obtained with the subject laying in a supine position and legs supported on a padded box to flatten the pelvis and lower spine (from the first to the fourth lumbar vertebra); the bright pointer was centered on the midpoint of the line joining the two superior iliac crests. The analysis was based upon the mean values of each vertebral BMD. Total and lumbar BMD and Z-score were used to evaluate bone metabolic status, according to international guidelines. 14 The Z-score quantifies BMD in adolescents, who have not yet reached the peak bone mass. It represents the value comparing with a healthy person of the same sex and same age of the patient.
Statistical analysis
All statistical analyses were carried out using the SPSS (Statistical Package of Social Sciences, Chicago, IL, USA) for Windows software program version 14.0.1. A P-value of o0.05 (two-tailed) was accepted as the level of significance. Data distribution was analyzed with skewness and kurtosis coefficients and Kolmogorov-Smirnov test. For normally distributed data, the statistical significance was assessed using one-way analysis of variance for multiple comparisons (Bonferroni test), Student's t-test, paired-sample t-test and Pearson's correlation index. For non-normally distributed data, Kruskal-Wallis, Mann-Whitney and Wilcoxon matched-pairs signed-rank tests and Spearman's correlation index computed on the ranks were used.
RESULTS
Clinical data
Forty-six out of seventy-nine patients (58.2%) completed the study. The final exclusion of 33 patients was due to drop out in 8/33 (24.2%), shifting into a different ED (for example, purging form) in 8/33 (24.2%), failing to undergo DXA evaluation within the 12 months in 10/33 (30.3%), poor compliance to treatment protocol in 7/33 (21.2%).
Baseline clinical data are shown in Table 1 , for the 46 patients analyzed.
At T0, 12/46-26.0% patients showed low BMC (referred to pediatric position of international society of clinical densitometry); 14 duration of amenorrhea and menarche did not produce any significant difference in BMI, Z-score and BMD (Table 1) .
After 12 months all patients showed a significant weight recovery (Po0.001). BMI sds was À 1.39±0.74 (range À 2.90/ À 1.40) at T0, and À 1.04±0.64 (range À 2.40/ À 1.30) at T12, with DBMI of 1.29 ± 1.85. Parameters are expressed in terms of average value and standard deviation.
Bone On the other hand, there was a significant reduction in LM% between T0 and T12 in all body regions (Po0.0001)-T0 78.9 ± 5.7, range 68.0-91.2; T12 74.5±5.7; range 61.3-85.4 ( Table 2 ).
Significant correlations appeared between delta BMI and delta FM% (P ¼ 0.02). FM% of all the districts showed such correlation, however, with higher to lower levels of significance: trunk (Po0.001-expression of preferential fat storage), android (Po0.005), gynoid (Po0.005), arms (Po0.05) and legs (P ¼ 0.05).
Bone status Patients lumbar Z-score at time 0 and at time 12 was respectively, À 1.14 ± 1.26 (range À 4.30/ À 1.9) and À 1.20 ± 1.16 (range À 4.00/ À 1.40), with a DZ-score of 0.06 ± 0.57, with no statistically significant change (P ¼ 0.22) (Table 3) .
Moreover, there was no statistically significant correlation among BMI sds, Z-score and BMD (P ¼ 0.3).
Clinical and densitometric correlations T12 menarche and duration of amenorrhea were not related to any bone composition parameters (Z-score and BMD).
Even if Z-score did not change significantly (P ¼ 0.22), we found higher values of delta Z-score in patients with spontaneously resumed menstrual cycle (P ¼ 0.01) ( Table 4) .
BMI sds did not change between patients performing any level of physical activity (competitive, amateur or not performing).
Z-score values at T1 and T12 (respectively P ¼ 0.007 at T0 and P ¼ 0.04 at T12) showed a statistically significant difference between the three physical activity groups. Z-score values were higher in the competitive activity group (Table 5) .
Delta LM% values decreased independently from any clinical variable, in particular, were not related to physical activity (P ¼ 0.56).
The medical treatment (antidepressants-antipsychotics-calcium and vitamin D) did not significantly influenced these findings.
DISCUSSION
The etiology of bone disease in ANR is complex and multifactorial. ANR appears to be a low turnover state characterized by increased bone resorption without a concomitant increase in bone formation. Estrogen deficiency was long felt to be the major factor. However, in contrast to postmenopausal osteoporosis, bone loss associated with ANR is related mainly to insufficient bone formation, with only a slight increase in bone resorption. This suggests a role for nutritional factors, such as disturbances in the growth hormone-somatomedin C axis (GH/Insulin-like Growth factor I-IGF-I) related to malnutrition. In fact hepatic synthesis of the bone trophic hormone, IGF-I, is also reduced in ANR. Low levels of IGF-I reduce the levels of osteocalcin, a marker of bone formation, and cause abnormalities in osteoblast function. These low levels of IGF-I have been demonstrated to be the major correlate of bone formation in ANR. Marker of bone resorption, such as N-telopeptide and deoxypyridinoline, shows higher blood levels in patient with ANR and markers of bone formation are not concomitantly elevated. However, serum levels of calcium, vitamin D and parathormone are all within the normal range in these patients. Differently the hypothalamic amenorrhea, characterizing ANR, is associated with low circulating levels of estradiol. 15 To analyze these complex neuroendocrine pathways in vivo, we decided to submit our patients to DXA evaluation. DXA allows, at the same diagnostic stage, the assessment of both bone parameters (Z-score and BMD) and body composition.
DXA is an accurate, reproducible, fast, relatively inexpensive technique that involves very low radiation dose to the patient. DXA measurements are based on a 3-compartment model of the molecular level of body composition that can be simplified into FM, LM and BMC. This technique is able to assess the three mass compartments regionally and whole body as well as it can measure whole-body BMD and Z-score. A strong correlation between DXA parameters and those of CT and MRI has been proved. 16 All these advantages allow this densitometric method to be ideal for clinical use and longitudinal studies, in both adults and children. In particular, the low dose and high accuracy make DXA a suitable tool for the evaluation and the follow-up of young female patients.
Significant bone loss occurs frequently and early among patients with ANR. Bone density is reduced at either the spine Abbreviation: BMI, body mass index. With the increase in BMI sds (that is, weight of patients), we observed an increase in fat mass levels while the lean mass decreased. The variation of all these three parameters was found to be statistically significant. Only adolescents with spontaneous resumption of menses showed a tendency in Z-score improvement. The difference between the three groups was statistically significant.
or the hip by more than 2.5 standard deviations (osteoporosis) in almost 40% of patients and by more than one standard deviation (osteopenia) in 92% of women with ANR; in adolescents, who have suffered from the disorder for only a short period, these percentages are lower, but however critical, consisting in a prevalence of 41% for osteopenia and 11% for osteoporosis.
3,17
Recovery of BMD in ANR is described as a slow process. It is a product of complex interactions between hormonal and nutritional factors, not completely understood. 18 Many discrepant results are in fact reported in the literature: from one side, osteoporosis was found to be associated with low body weight, longer duration of amenorrhea/disease and inverse related to age at menarche. On the other side, there is emerging evidence that loss of BMD is rapid, occurring relatively early in the disease (severe levels of demineralization could be observed even in adolescents with a brief duration of illness); moreover, the role of weight recovery on restoration of normal bone status has not been completely cleared. 3, 19 Even on effects of physical activity in ANR, contradictory results were achieved; it is generally assumed that weight-bearing exercise may be protective if menstruation is preserved, but that could be deleterious when excessive and associated with amenorrhea; 20 however, some uncontrolled trials have shown a potential protective action of exercise on bone status. 21 In our results we observed that, despite the efficacy of the treatment protocol in terms of increase in BMI, bone condition at 12 months did not change. Moreover, we did not observe any statistical correlations between Z-score and BMI. Thus, after 12 months, weight recovery did not influence the reestablishment of concrete bone mineralization.
In contrast to what already reported, the presence/absence of menarche, as well as duration of amenorrhea period was not found to be related to bone mineralization values at baseline and after 12 months. The pediatric population considered in this study can in part explain this discrepancy.
However, in the group of patients with spontaneous recovery of menses, we observed a tendency in Z-score improvement; moreover, patients performing competitive sport seemed to be partially protected from bone loosing (normal values of Z-score).
Thus, from our data bone recovery was found to be not influenced by BMI, with a slight positive correlation with spontaneous relapse of menstruation and competitive sport.
Our results are in line with contradictory point of views assessed in the literature and suggest that more efforts should be done to understand the complex pathways 'mining' bone status in ANR, to better target the therapy (to date, bone loosing is considered as almost irreversible, with modest and slow regaining of normal status). Moreover, it should be considered that the natural history of bone disease (onset and follow-up) could be different in adolescents and adults, with a possible different evolution.
In terms of body composition changes, BMI was related to an increase in FM, with a concomitant reduction in LM. This outcome was assessed in all patients, even those performing physical activity, leading to the conclusion that weight recovery is due to a growth of adipose tissue mass. In addition, as previously reported by some authors, the re-feeding period showed a preferential redistribution of FM in trunk region, with low levels in lower and upper arms (Figure 1 ). This sort of Cushingoid phenotype could be the expression of hypercortisolemia in ANR. 22, 23 Patients with ANR are reported to present elevated levels of total and free serum cortisol and high 24 h urinary-free cortisol excretion. Cortisol basal level increase seems to be due to both hyperincretion and clearance metabolic decrease. In the acute phase of ANR, the hyperincretion is determined by a corticotropin releasing hormone raise, and a consequent adrenocorticotropic hormone (ACTH) increase, stimulating adrenal glands. Moreover, it is shown a missing suppression of cortisol and ACTH levels after dexamethasone suppression test. Usually, no clinical signs are detectable for hypercortisolism; however, in the re-feeding stage, an abnormal distribution of adipose tissue can be observed. This phenomenon is supposed to represent a consequence of an overcompensation fat regain after the starvation period and should be taken into consideration as a risk factor for the relapse of disease (the distortion of body image could be exacerbated by the real occurrence of FM increase with the presence of waist adiposity). 24, 25 Moreover, it is well known how this may be detrimental for general health. As a matter of fact, central (trunk) phenotype is associated with visceral predominance of fat distribution, with potential negative effects on the cardiovascular future of patients. 26 Furthermore, insufficient muscle trophism may determine several bad consequences for the bone status and the whole skeletal system.
The main limit of this study is the short-term follow-up, which requires a confirmation in a longer assessment, especially regarding conclusions on bone metabolism and fat-associated risk factors; besides, we did not consider correlation with other parameters (such as IGF-1 and cortisol levels) and it was a single-cohort study, without a controlled group. However, the importance of our results lies on the multiparametric evaluation of a pediatric ANR population (not only bone, but also body composition changes which have been poorly studied in ANR and which are today central in several investigations related to bone and clinical outcome) related to some important clinical parameters (physical activity and hormonal status). To our knowledge, no one investigated the relationships between these parameters, bone loss and body composition changes.
In conclusion, we propose DXA evaluation both in acute and in the re-feeding stage of ANR, since it is a low-dose technique that allows several different measures and could help the clinicians to understand mechanisms implicated with personal treatment. Our Table 5 . BMI sds and lumbar Z-score values at baseline (T0) and after 12 months (T12) in patients not performing sports or performing amateur/ competitive physical activity Sport BMI sds T0 BMI sds T12 Z-score T0 Z-score T12
findings suggest that the increase in body weight is not related to the reestablishment of normal bone values, at least after 1 year; on the other hand, weight recovery was associated with the increase in FM and a distortion of its distribution, more evident in trunk region (potential risk factor for the relapse of the the psychiatric condition and for the development of cardiovascular and metabolic diseases). Though significant conclusions on bone metabolic condition could not be reached, we observed that competitive sport partially protected from bone demineralization, but that only the spontaneous resumption of menses was related to an improvement of Z-score values. ) with a consensual improvement of FM, more evident in the trunk and in the gynoid region. NB: these pictures do not have diagnostic purposes, but they only visually clarify the distribution of adipose tissue in the body.
